Multifocal motor neuropathy: a study on immunological mechanisms and natural history
- Conditions
- disease of motor nervesinflammatory demyelinating peripheral motor neuropathy10012303
- Registration Number
- NL-OMON44983
- Lead Sponsor
- niversitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 320
Patients are subjects who fullfil the diagnostic consensus criteria for MMN (see protocol, page 40)
Controls are people who visit the neuromuscular outpatient clinic for diseases other than MMN.
All subjects are older than 18 year, are not mentally incapacitated and fully understand the given information for the study
An MMN patient who meets any of the following criteria will be excluded from participation in this study:
- Doubts about the diagnosis MMN
- Relevant concomitant illnesses (i.e. haematological or immunological diseases) that may interfere with any part of the study
A control will be excluded when any of the following criteria is met:
- having MMN as a diagnosis in the history
- under 18 years old.
- not capable of understanding the given information or giving consent.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Natural history:<br /><br>Clinical disease course is determined by questionnaires and a neurological<br /><br>examination taken in 2007 and in the current study. Special (clinical) features<br /><br>is looked for in patients that have poor prognosis.<br /><br>Quality of life scores compared to the standardized Dutch scores.<br /><br><br /><br>Immunological part:<br /><br>Anti-GM1 IgM titers and HLA haplotyping in MMN and controles<br /><br>-FcuR status on (subsets of) leukocytes is compared with controls.<br /><br>- Bacterial cultures that can express GM1 (like) epitopes is compared with<br /><br>controls.</p><br>
- Secondary Outcome Measures
Name Time Method <p>not applicable</p><br>